SH3G2 antibody (Internal Region)
Quick Overview for SH3G2 antibody (Internal Region) (ABIN1049509)
Target
See all SH3G2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- Internal Region
-
Purpose
- Endophilin-A1 / SH3GL2
-
Sequence
- SLEFPTGDST QPN
-
Cross-Reactivity
- Human, Pig
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-SLEFPTGDSTQPN, from the of the protein sequence according to NP_003017.1.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Immunohistochemistry: In paraffin embedded Human Cerebral Cortex shows staining of cytoplasm in some but not all neuronal cells. Recommended concentration, 5-10 μg/mL.
Western Blot: Approx 38 kDa band observed in Human Brain (Frontal Cortex) lysates (calculated MW of 40.0 kDa according to NP_003017.1). Recommended concentration: 0.3-1 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:64000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- SH3G2 (Endophilin-A1 (SH3G2))
-
Alternative Name
- SH3GL2
-
Background
- SH3GL2, SH3-domain GRB2-like 2, CNSA2, EEN-B1, FLJ20276, FLJ25015, SH3D2A, SH3P4, Endophilin A1 BAR domain, OTTHUMP00000021084, SH3 domain protein 2A, SH3 domain-containing GRB2-like protein 2, bA335L15.1 (SH3-domain GRB2-like 2), endophilin-1, endophilin
-
Gene ID
- 6456
-
NCBI Accession
- NP_003017
-
Pathways
- Neurotrophin Signaling Pathway, EGFR Downregulation
Target
-